Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malato

Showing results (221-230 of 274) with videos related to

Pageof 28
Sort By:
Frontiers in Medicine|July 11, 2022
Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease DiagnosisNuno Sepúlveda, João Malato, Franziska Sotzny, et al.
Blood|May 24, 2008
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) studySergio Siragusa, Alessandra Malato, Raffaela Anastasio, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2017
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up studyS Barco, F Pomero, M N D Di Minno, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasitesFranziska Hentzschel, Christiane Hammerschmidt-Kamper, Kathleen Börner, et al.
Plos One|April 25, 2019
Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort studyVatthanaphone Latthaphasavang, Philippe Vanhems, Nicole Ngo-Giang-Huong, et al.
Haematologica|May 14, 2026
Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of Iclusig® (ponatinib) treatment in patients with chronic myeloid leukemia in ItalyMassimo Breccia, Alessandra Iurlo, Fabrizio Pane, et al.
Journal of Clinical Medicine|April 12, 2022
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental TransferElisabetta Abruzzese, Stefano Aureli, Francesco Bondanini, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studiesJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Heliyon|August 3, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression dataJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Pageof 28

Showing results (221-230 of 274) with videos related to

Sort By:
Pageof 28
Frontiers in Medicine|July 11, 2022
Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease DiagnosisNuno Sepúlveda, João Malato, Franziska Sotzny, et al.
Blood|May 24, 2008
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) studySergio Siragusa, Alessandra Malato, Raffaela Anastasio, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2017
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up studyS Barco, F Pomero, M N D Di Minno, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasitesFranziska Hentzschel, Christiane Hammerschmidt-Kamper, Kathleen Börner, et al.
Plos One|April 25, 2019
Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort studyVatthanaphone Latthaphasavang, Philippe Vanhems, Nicole Ngo-Giang-Huong, et al.
Haematologica|May 14, 2026
Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of Iclusig® (ponatinib) treatment in patients with chronic myeloid leukemia in ItalyMassimo Breccia, Alessandra Iurlo, Fabrizio Pane, et al.
Journal of Clinical Medicine|April 12, 2022
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental TransferElisabetta Abruzzese, Stefano Aureli, Francesco Bondanini, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studiesJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Heliyon|August 3, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression dataJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Pageof 28